Latest filing published 03 Jun 2024 for Orchestra BioMed Holdings, Inc., €26k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -58.7%Entry US$7.90 · Close at T+365 US$3.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Reed Little: trading record in brief
William Reed Little is a declared insider of Orchestra BioMed Holdings, Inc., with filings sourced from SEC (Form 4). Between 20 July 2023 and 30 May 2024, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €26k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants. Since January 2024: 1 purchase and no sales on the market.
Most recently, on 3 June 2024, the filings show an open-market purchase worth €26k in Orchestra BioMed Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William Reed Little
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$7.00100.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-067788:0Canonical exit: 28 Aug 2024 (T+90)
- 53,333 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-059992:0
- 250,526 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083500:0
3 of 3 declarations
